Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
22-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
22-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #28806
advertisement
Wang P
19
Showing records 1 to 19 |
Display all abstracts from
Wang P
98219
Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019
Zafar S
Ophthalmology
2022; 129: 250-257
99349
Surgical Resection of Intraocular Tumors (Partial Transscleral Sclerouvectomy Combined With Mircoinvasive Vitrectomy and Reconstruction of the Eyeball) in Asian Patients: Twenty-Five Years Results
Zhou N
Frontiers in oncology
2022; 12: 768635
99111
Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change
Lin F
Ophthalmology
2022; 129: 803-812
98219
Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019
Dun C
Ophthalmology
2022; 129: 250-257
99111
Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change
Chen S
Ophthalmology
2022; 129: 803-812
99349
Surgical Resection of Intraocular Tumors (Partial Transscleral Sclerouvectomy Combined With Mircoinvasive Vitrectomy and Reconstruction of the Eyeball) in Asian Patients: Twenty-Five Years Results
Wang P
Frontiers in oncology
2022; 12: 768635
98219
Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019
Srikumaran D
Ophthalmology
2022; 129: 250-257
99349
Surgical Resection of Intraocular Tumors (Partial Transscleral Sclerouvectomy Combined With Mircoinvasive Vitrectomy and Reconstruction of the Eyeball) in Asian Patients: Twenty-Five Years Results
Xu X
Frontiers in oncology
2022; 12: 768635
99111
Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change
Song Y
Ophthalmology
2022; 129: 803-812
98219
Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019
Wang P
Ophthalmology
2022; 129: 250-257
99349
Surgical Resection of Intraocular Tumors (Partial Transscleral Sclerouvectomy Combined With Mircoinvasive Vitrectomy and Reconstruction of the Eyeball) in Asian Patients: Twenty-Five Years Results
Liu Y
Frontiers in oncology
2022; 12: 768635
99111
Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change
Li F
Ophthalmology
2022; 129: 803-812
99349
Surgical Resection of Intraocular Tumors (Partial Transscleral Sclerouvectomy Combined With Mircoinvasive Vitrectomy and Reconstruction of the Eyeball) in Asian Patients: Twenty-Five Years Results
Wei W
Frontiers in oncology
2022; 12: 768635
98219
Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019
Schein OD
Ophthalmology
2022; 129: 250-257
99111
Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change
Wang W
Ophthalmology
2022; 129: 803-812
98219
Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019
Makary M
Ophthalmology
2022; 129: 250-257
99111
Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change
Zhao Z
Ophthalmology
2022; 129: 803-812
98219
Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019
Woreta F
Ophthalmology
2022; 129: 250-257
99111
Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change
Gao X; Wang P; Jin L; Liu Y; Chen M; Liang X; Yang B; Ning G; Ning G; Cheng CY; Healey PR; Park KH; Zangwill LM; Aung T; Ohno-Matsui K; Jonas JB; Weinreb RN; Zhang X;
Ophthalmology
2022; 129: 803-812
Issue
22-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept